These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 30700578

  • 21. Visualization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein.
    Michalowski S, Miller JW, Urbinati CR, Paliouras M, Swanson MS, Griffith J.
    Nucleic Acids Res; 1999 Sep 01; 27(17):3534-42. PubMed ID: 10446244
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice.
    Roberts R, Timchenko NA, Miller JW, Reddy S, Caskey CT, Swanson MS, Timchenko LT.
    Proc Natl Acad Sci U S A; 1997 Nov 25; 94(24):13221-6. PubMed ID: 9371827
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Recent Progress and Challenges in the Development of Antisense Therapies for Myotonic Dystrophy Type 1.
    De Serres-Bérard T, Ait Benichou S, Jauvin D, Boutjdir M, Puymirat J, Chahine M.
    Int J Mol Sci; 2022 Nov 01; 23(21):. PubMed ID: 36362145
    [Abstract] [Full Text] [Related]

  • 26. Myotonic dystrophy type 1: role of CCG, CTC and CGG interruptions within DMPK alleles in the pathogenesis and molecular diagnosis.
    Santoro M, Masciullo M, Silvestri G, Novelli G, Botta A.
    Clin Genet; 2017 Oct 01; 92(4):355-364. PubMed ID: 27991661
    [Abstract] [Full Text] [Related]

  • 27. A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levels.
    Reddy K, Jenquin JR, McConnell OL, Cleary JD, Richardson JI, Pinto BS, Haerle MC, Delgado E, Planco L, Nakamori M, Wang ET, Berglund JA.
    Proc Natl Acad Sci U S A; 2019 Oct 15; 116(42):20991-21000. PubMed ID: 31570586
    [Abstract] [Full Text] [Related]

  • 28. A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type I.
    Zhang F, Bodycombe NE, Haskell KM, Sun YL, Wang ET, Morris CA, Jones LH, Wood LD, Pletcher MT.
    Hum Mol Genet; 2017 Aug 15; 26(16):3056-3068. PubMed ID: 28535287
    [Abstract] [Full Text] [Related]

  • 29. Reduced cytoplasmic MBNL1 is an early event in a brain-specific mouse model of myotonic dystrophy.
    Wang PY, Lin YM, Wang LH, Kuo TY, Cheng SJ, Wang GS.
    Hum Mol Genet; 2017 Jun 15; 26(12):2247-2257. PubMed ID: 28369378
    [Abstract] [Full Text] [Related]

  • 30. A low absolute number of expanded transcripts is involved in myotonic dystrophy type 1 manifestation in muscle.
    Gudde AE, González-Barriga A, van den Broek WJ, Wieringa B, Wansink DG.
    Hum Mol Genet; 2016 Apr 15; 25(8):1648-62. PubMed ID: 26908607
    [Abstract] [Full Text] [Related]

  • 31. Molecular Effects of the CTG Repeats in Mutant Dystrophia Myotonica Protein Kinase Gene.
    Llamusí B, Artero R.
    Curr Genomics; 2008 Dec 15; 9(8):509-16. PubMed ID: 19516957
    [Abstract] [Full Text] [Related]

  • 32. Genome Editing of Expanded CTG Repeats within the Human DMPK Gene Reduces Nuclear RNA Foci in the Muscle of DM1 Mice.
    Lo Scrudato M, Poulard K, Sourd C, Tomé S, Klein AF, Corre G, Huguet A, Furling D, Gourdon G, Buj-Bello A.
    Mol Ther; 2019 Aug 07; 27(8):1372-1388. PubMed ID: 31253581
    [Abstract] [Full Text] [Related]

  • 33. Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9.
    Wang Y, Hao L, Wang H, Santostefano K, Thapa A, Cleary J, Li H, Guo X, Terada N, Ashizawa T, Xia G.
    Mol Ther; 2018 Nov 07; 26(11):2617-2630. PubMed ID: 30274788
    [Abstract] [Full Text] [Related]

  • 34. Stabilization of expanded (CTG)•(CAG) repeats by antisense oligonucleotides.
    Nakamori M, Gourdon G, Thornton CA.
    Mol Ther; 2011 Dec 07; 19(12):2222-7. PubMed ID: 21971425
    [Abstract] [Full Text] [Related]

  • 35. Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model.
    Amack JD, Paguio AP, Mahadevan MS.
    Hum Mol Genet; 1999 Oct 07; 8(11):1975-84. PubMed ID: 10484765
    [Abstract] [Full Text] [Related]

  • 36. Mutant DMPK 3'-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD.
    Amack JD, Reagan SR, Mahadevan MS.
    J Cell Biol; 2002 Nov 11; 159(3):419-29. PubMed ID: 12427866
    [Abstract] [Full Text] [Related]

  • 37. The myotonic dystrophy expanded CUG repeat tract is necessary but not sufficient to disrupt C2C12 myoblast differentiation.
    Amack JD, Mahadevan MS.
    Hum Mol Genet; 2001 Sep 01; 10(18):1879-87. PubMed ID: 11555624
    [Abstract] [Full Text] [Related]

  • 38. Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios.
    Tiscornia G, Mahadevan MS.
    Mol Cell; 2000 Jun 01; 5(6):959-67. PubMed ID: 10911990
    [Abstract] [Full Text] [Related]

  • 39. Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing.
    Izzo M, Battistini J, Provenzano C, Martelli F, Cardinali B, Falcone G.
    Int J Mol Sci; 2022 Apr 21; 23(9):. PubMed ID: 35563013
    [Abstract] [Full Text] [Related]

  • 40. Myotonic dystrophy--a multigene disorder.
    Larkin K, Fardaei M.
    Brain Res Bull; 2022 Apr 21; 56(3-4):389-95. PubMed ID: 11719277
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.